Stow N D, Hammarsten O, Arbuckle M I, Elias P
Medical Research Council Virology Unit, Institute of Virology, Glasgow, United Kingdom.
Virology. 1993 Oct;196(2):413-8. doi: 10.1006/viro.1993.1496.
The herpes simplex virus type 1 (HSV-1) origin-binding protein (OBP) is a sequence-specific DNA binding protein encoded by gene UL9 which interacts with the viral origins of DNA replication and also exhibits DNA helicase activity. Sequence-specific DNA binding activity has previously been shown to reside within the C-terminal 317 amino acids, and when expressed alone, this domain exerts a dominant inhibitory effect on HSV-1 DNA synthesis. We have tested several UL9 gene mutants for ability to support or interfere with viral DNA replication. Mutants affected in an ATP binding motif presumed to be associated with DNA helicase activity (ATP-), or defective in origin binding (OBP-) were unable to support replication in a transient assay for HSV-1 origin-dependent DNA synthesis. When the products were screened for their ability to interfere with replication, the ATP- but not the OBP- mutant was inhibitory. Introduction of a mutation which abolished origin-binding activity into the isolated C-terminal fragment also removed the ability to interfere. The C-terminal fragment retained inhibitory activity when the wild-type (wt) protein was specified by a plasmid in which an OBP recognition site within the UL9 gene coding region had been mutated so as to prevent binding without affecting the encoded amino acids. These results suggest that in this assay inhibition of DNA synthesis probably results primarily from competition between mutant and wt forms of OBP for binding to the viral replication origins. The infectivity of HSV-1 DNA in co-transfection experiments was greatly reduced by mutant UL9 proteins which interfered with origin-dependent DNA replication and also by high level expression of the wt polypeptide.
单纯疱疹病毒1型(HSV-1)的起始结合蛋白(OBP)是一种由UL9基因编码的序列特异性DNA结合蛋白,它与病毒DNA复制起始位点相互作用,并且还具有DNA解旋酶活性。先前已证明序列特异性DNA结合活性存在于C末端的317个氨基酸内,并且当单独表达时,该结构域对HSV-1 DNA合成具有显性抑制作用。我们测试了几种UL9基因突变体支持或干扰病毒DNA复制的能力。在推测与DNA解旋酶活性相关的ATP结合基序中受影响的突变体(ATP-),或起始结合缺陷的突变体(OBP-),在针对HSV-1起始依赖性DNA合成的瞬时测定中无法支持复制。当筛选产物干扰复制的能力时,ATP-突变体具有抑制作用,而OBP-突变体则没有。将一个消除起始结合活性的突变引入分离的C末端片段也消除了干扰能力。当野生型(wt)蛋白由一个质粒指定时,C末端片段保留了抑制活性,在该质粒中UL9基因编码区内的一个OBP识别位点已发生突变,以防止结合而不影响编码的氨基酸。这些结果表明,在该测定中,DNA合成的抑制可能主要源于突变型和野生型OBP形式之间竞争与病毒复制起始位点结合。在共转染实验中,干扰起始依赖性DNA复制的突变型UL9蛋白以及野生型多肽的高水平表达大大降低了HSV-1 DNA的感染性。